Skip to menu Skip to content Skip to footer

2018

Journal Article

A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care

Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Bernard, Anne, Brown, Nigel Neil, Lampe, Guy, Buck, Lyndall, Saad, Nivene, Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Rosenberg, William and Powell, Elizabeth Ellen (2018). A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatology Communications, 2 (8), 893-905. doi: 10.1002/hep4.1208

A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care

2018

Journal Article

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath, Divya, Irvine, Katharine M., Lukowski, Samuel W., Horsfall, Leigh U., Loh, Zhixuan, Clouston, Andrew D., Patel, Preya J., Fagan, Kevin J., Iyer, Abishek, Lampe, Guy, Stow, Jennifer L., Schroder, Kate, Fairlie, David P., Powell, Joseph E., Powell, Elizabeth E. and Sweet, Matthew J. (2018). Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight, 3 (14) e120274. doi: 10.1172/jci.insight.120274

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

2018

Journal Article

Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis

Patel, Preya J., Banh, Xuan, Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew, Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C., Williams, Suzanne and Powell, Elizabeth E (2018). Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Medicine Journal, 48 (2), 144-151. doi: 10.1111/imj.13667

Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis

2018

Journal Article

Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis

Maradana, Muralidhara Rao, Yekollu, Suman Kumar, Zeng, Bijun, Ellis, Jonathan, Clouston, Andrew, Miller, Gregory, Talekar, Meghna, Bhuyan, Zaied Ahmed, Mahadevaiah, Sachin, Powell, Elizabeth E., Irvine, Katharine M., Thomas, Ranjeny and O'Sullivan, Brendan John (2018). Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism: Clinical and Experimental, 78, 80-94. doi: 10.1016/j.metabol.2017.09.002

Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis

2017

Journal Article

Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease

Patel, Preya J., Smith, David, Connor, Jason P., Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew D., Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C. and Powell, Elizabeth E. (2017). Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease. Canadian Journal of Gastroenterology and Hepatology, 2017 (1) 7927685, 7927685-8. doi: 10.1155/2017/7927685

Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease

2017

Journal Article

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

Hayward, Kelly L., Valery, Patricia C., Martin, Jennifer H., Karmakar, Antara, Patel, Preya J., Horsfall, Leigh U., Tallis, Caroline J., Stuart, Katherine A., Wright, Penny L., Smith, David D., Irvine, Katharine M., Powell, Elizabeth E. and Cottrell, W. Neil (2017). Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World Journal of Gastroenterology, 23 (40), 7321-7331. doi: 10.3748/wjg.v23.i40.7321

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

2017

Journal Article

Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management

Hayward, Kelly L., Horsfall, Leigh U., Ruffin, Brittany J., Cottrell, W. Neil, Chachay, Veronique S., Irvine, Katharine M., Martin, Jennifer H., Powell, Elizabeth E. and Valery, Patricia C. (2017). Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management. Internal Medicine Journal, 47 (8), 952-955. doi: 10.1111/imj.13505

Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management

2017

Journal Article

Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management

Patel, Preya Janubhai, Hayward, Kelly Lee, Rudra, Rathiga, Horsfall, Leigh Ula, Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Clouston, Andrew Donald, Stuart, Katherine Anne, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Russell, Anthony William and Powell, Elizabeth Ellen (2017). Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management. Medicine, 96 (26) e6761, e6761. doi: 10.1097/MD.0000000000006761

Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management

2017

Journal Article

Identifying areas of need relative to liver disease: geographic clustering within a health service district

El-Atem, Nathan, Irvine, Katharine M., Valery, Patricia C., Wojcik, Kyle, Horsfall, Leigh, Johnson, Tracey, Janda, Monika, McPhail, Steven M. and Powell, Elizabeth E. (2017). Identifying areas of need relative to liver disease: geographic clustering within a health service district. Australian Health Review, 41 (4), 407-418. doi: 10.1071/AH15225

Identifying areas of need relative to liver disease: geographic clustering within a health service district

2026

Journal Article

Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet‐induced obesity

Wang, Yizhuo, Ramnath, Divya, Das Gupta, Kaustav, Prakrithi, P., Bisht, Kavita, Miller, Gregory C., Xiong, Zherui, Wan, Yujun, Tejo, Ellen N., Curson, James E. B., Abrol, Rishika, Keshvari, Sahar, Gunther, Kimberley S., Atkinson, Jordan D., Loh, Zhixuan, Engel, Jessica A., Engwerda, Christian R., Burgener, Sabrina Sofia, Schroder, Kate, Fairlie, David P., Clouston, Andrew D., Powell, Elizabeth E., Irvine, Katharine M., Sullivan, Mitchell A., Lévesque, Jean‐Pierre, Nguyen, Quan, Sweet, Matthew J. and Karunakaran, Denuja (2026). Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet‐induced obesity. Clinical and Translational Immunology, 15 (6) e70100, 1-20. doi: 10.1002/cti2.70100

Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet‐induced obesity

2026

Journal Article

Spleen size may also be an important prognostic indicator of liver-related outcomes in metabolic-dysfunction-associated steatotic liver disease patients without clinically significant portal hypertension

Chang, David R., Hartel, Gunter, Nguyen, Thy, McLean, Kate, Stuart, Katherine A., Valery, Patricia C., Irvine, Katharine, Powell, Elizabeth E. and Chouhan, Manil D. (2026). Spleen size may also be an important prognostic indicator of liver-related outcomes in metabolic-dysfunction-associated steatotic liver disease patients without clinically significant portal hypertension. Journal of Clinical and Experimental Hepatology, 16 (3) 103522, 1-3. doi: 10.1016/j.jceh.2026.103522

Spleen size may also be an important prognostic indicator of liver-related outcomes in metabolic-dysfunction-associated steatotic liver disease patients without clinically significant portal hypertension

2026

Journal Article

Agreement between exercise physiologists and nurses in Fibroscan™ assessment of liver stiffness: strengthening community liver screening capacity

Keating, Shelley, Aikebuse, Melanie, Bruggisser, Fabienne, Muollo, Valentina, Hickman, Ingrid, Coombes, Jeff and Powell, Elizabeth (2026). Agreement between exercise physiologists and nurses in Fibroscan™ assessment of liver stiffness: strengthening community liver screening capacity. Journal of Clinical Exercise Physiology, 15 (s2), 168-168. doi: 10.31189/2165-7629-15-s2.168

Agreement between exercise physiologists and nurses in Fibroscan™ assessment of liver stiffness: strengthening community liver screening capacity

2026

Journal Article

Why your patient may need a Bankart repair plus remplissage

Momaya, Amit M., Broussard, Joshua P. and Powell, Elizabeth (2026). Why your patient may need a Bankart repair plus remplissage. International Journal of Sports Physical Therapy, 21 (3). doi: 10.26603/001c.158195

Why your patient may need a Bankart repair plus remplissage

2026

Journal Article

Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence

Vu, Hani, Sun, Yuliangzi, Xiong, Zherui, Tan, Xiao, Radford-Smith, Daniel, Causer, Andrew, Dickens, Alex M., Hyötyläinen, Tuulia, Evstafev, Ilia, Oresic, Matej, Nefzger, Christian, O’Sullivan, Eoin D., Watt, Matthew J., Ramm, Grant A., Clouston, Andrew, Irvine, Katharine, Nguyen, Quan H. and Powell, Elizabeth E. (2026). Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence. JHEP Reports, 8 (2) 101657, 1-12. doi: 10.1016/j.jhepr.2025.101657

Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence

2025

Journal Article

MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response

Li, Chaoyi, Nguyen, Quan H., Irvine, Katharine, Powell, Elizabeth E. and Clouston, Andrew (2025). MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response. Journal of Hepatology, 84 (4), e135-e137. doi: 10.1016/j.jhep.2025.11.006

MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response

2025

Journal Article

Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study

Bhasker, Vikas, Fong, Jessica R., Clark, Paul J., Hartel, Gunter F., Skoien, Richard, O'Beirne, James, Powell, Elizabeth E. and Valery, Patricia C. (2025). Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study. Medical Journal of Australia, 223 (9), 473-483. doi: 10.5694/mja2.70036

Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study

2025

Other Outputs

Spatial Transcriptomic Signature of Progressive Fibrosis in Human MASLD: Role of Senescence and Metabolic Reprogramming

Vu, Hani, Sun, Yuliangzi, Xiong, Zherui, Tan, Xiao, Irvine, Katharine, Nguyen, Quan H. and Powell, Elizabeth E. (2025). Spatial Transcriptomic Signature of Progressive Fibrosis in Human MASLD: Role of Senescence and Metabolic Reprogramming. The University of Queensland. (Dataset) doi: 10.48610/e95155f

Spatial Transcriptomic Signature of Progressive Fibrosis in Human MASLD: Role of Senescence and Metabolic Reprogramming

2025

Journal Article

Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary

Adams, Leon A., Kemp, William W., Muller, Kate R., Powell, Elizabeth E., Roberts, Stuart K., Bertot, Luis Calzadilla, Best, Stephanie, Deed, Gary, Emery, Jon D., Hocking, Samantha L., Jones, Graham R., Lubel, John S., Sheils, Sinead, Twigg, Stephen M., Watts, Gerald F. and George, Jacob (2025). Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary. Medical Journal of Australia, 223 (5), 268-276. doi: 10.5694/mja2.70008

Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary

2025

Journal Article

A new classification system for fatty liver-what sonographers should know

Keys, Elspeth L., McMahon, Katie L., Powell, Elizabeth, Allen, Heather and Edwards, Christopher (2025). A new classification system for fatty liver-what sonographers should know. Sonography, 12 (3) sono.12519, 374-380. doi: 10.1002/sono.12519

A new classification system for fatty liver-what sonographers should know

2025

Journal Article

Co-designing approaches to sustainable exercise care for people with metabolic dysfunction-associated steatotic liver disease

Keating, Shelley E., de Boer, Jack, Catsoulis, Georgina, Stine, Jonathan G., Goode, Ana, Macdonald, Graeme A., Powell, Elizabeth and Hickman, Ingrid J. (2025). Co-designing approaches to sustainable exercise care for people with metabolic dysfunction-associated steatotic liver disease. Journal of Clinical and Translational Hepatology, 13 (9), 707-722. doi: 10.14218/jcth.2025.00155

Co-designing approaches to sustainable exercise care for people with metabolic dysfunction-associated steatotic liver disease